Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Activation of kappa opioid receptor (KOR) signaling increases... | Download Scientific Diagram
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
κ-opioid receptor - Wikipedia
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Activation of opioid receptors in the enteric nervous system. MOR mu... | Download Scientific Diagram
Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications - ScienceDirect
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
Pathways and Receptors – Opioid Peptides
Kappa opioid receptor labeled with Tb (HTRF transiently expressing cells)
Development of κ opioid receptor antagonists. | Semantic Scholar
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Kappa Opioid Receptor, molecular model Stock Photo - Alamy
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Opioids in cancer: The κ‑opioid receptor (Review)
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
